Why Only IncreaseMyT’s Troche Peptides Rival Injectable Strength for GH Stimulation – For Men and Women

At IncreaseMyT, we specialize in advanced hormone optimization to help both men and women achieve peak performance, energy, recovery, and vitality. While injectable peptides have long been the gold standard for boosting growth hormone (GH), only our proprietary sublingual troche formulation delivers truly comparable potency—without needles. The secret lies in the troche delivery: a dissolvable lozenge that melts under the tongue for direct absorption through the oral mucous membranes. Standard capsules or tablets (swallowed) simply can't compete, as peptides are destroyed by stomach acid, digestive enzymes, and liver first-pass metabolism, resulting in negligible effectiveness. Our high-dose GHRH + GHRP combo troches change that equation, offering injectable-level results in a convenient, needle-free format suitable for both men and women seeking natural GH support.

The Key Difference: Troche Delivery Beats Capsules/Tablets

IncreaseMyT peptides come as sublingual troches—small lozenges placed under the tongue to dissolve slowly. This allows direct entry into the bloodstream via the rich vascular network in the oral mucosa, completely bypassing the harsh gastrointestinal tract and liver first-pass metabolism.

Studies highlight this advantage:Swallowed oral peptides (capsules/tablets) suffer from very low bioavailability, often <1–2%, due to enzymatic breakdown and poor gut permeability. (PMC: Approaches for Enhancing Oral Bioavailability of Peptides)

Sublingual/troche routes achieve much higher rates, with research showing 15–50% bioavailability in optimized formulations, and some studies reporting up to 36% for peptides.  (ScienceDirect: Sublingual Administration)

Capsules/tablets open in the stomach, where peptides are rapidly degraded before meaningful absorption—rendering most generic oral products ineffective for systemic GH effects. Troches avoid this destruction, delivering active compound intact and reliably. This is why only troche-based options like IncreaseMyT’s can approach injectable potency for both men and women.

High-Dose Design: 800/800 mcg for Peak Stimulation

Our troches contain an aggressive 800 mcg GHRH analog + 800 mcg GHRP per dose. Using a conservative 20% absorption rate (well-supported by sublingual peptide data), this delivers an effective ~320 mcg systemically—more than enough for peak GH stimulation equivalent to typical injectable protocols.

Many other oral forms use lower doses or swallowed delivery, resulting in far less effective amounts due to poor bioavailability. IncreaseMyT’s troche-specific high dosing ensures consistent, potent benefits like enhanced energy, muscle recovery, fat metabolism, and overall vitality—effects reported by both men and women that often match injectables.

Powerful Synergy: GHRH + GHRP Combo in Every Troche

IncreaseMyT exclusively combines a GHRH (e.g., sermorelin) with a GHRP (e.g., GHRP-2/6) in one troche. This dual mechanism creates true synergy:

- GHRH amplifies pituitary GH production.
- GHRP triggers robust release via complementary pathways, suppressing somatostatin inhibition.

Research shows combined GHRH + GHRP boosts GH amplitude by 3–5 times (or more) compared to either alone, with higher peaks, greater area under the curve, and sustained secretion. (NCBI: Determinants of GH-releasing hormone and GH-releasing peptide synergy) (American Journal of Physiology: GHRP-2 in GHRH knockout mouse)Clinics offering sermorelin (a GHRH analog) alone provide only modest GH increases—studies confirm limited meaningful impact without a GHRP partner. (PMC: Beyond the androgen receptor) Our troche combo unlocks full amplification that single-peptide or generic oral options simply cannot achieve.

Why Only IncreaseMyT’s Troche Peptides Deliver Injectable-Level Power

Most oral peptides rely on capsules/tablets and deliver minimal systemic benefit due to near-total destruction in digestion. IncreaseMyT stands alone because:

Troche delivery enables direct mucous membrane absorption (15–50% bioavailability) vs. <1–2% for swallowed forms.

- High-dose 800/800 mcg formulation ensures peak stimulation despite variability.
- Exclusive GHRH + GHRP synergy for amplified, natural GH response.
- Needle-free convenience with no injection risks or hassle—ideal for both men and women.

Whether you're a man optimizing performance or a woman supporting vitality and recovery, IncreaseMyT’s troche peptides offer the only oral solution engineered for real, injectable-comparable strength. Explore our formulation today and consult our experts to see if it fits your goals.